Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression
Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression
复制标题
DOI:
10.1002/jgm.1317
复制
发表时间:
2009-05-01
影响因子:
3.5
通讯作者:
Takakura, Yoshinobu
中科院分区:
文献类型:
--
作者:
Mitsui, Masaru;Nishikawa, Makiya;Takakura, Yoshinobu
Background Nonviral gene transfer generally suffers from short-term expression of transgenes. We have previously demonstrated that plasmids with reduced CpG content exhibited a more prolonged expression of murine. interferon (IFN)-beta or IFN-gamma, which was effective in inhibiting metastatic tumor growth. A further extension of the duration of transgene expression could be achieved by controlling the number and location of CpG motifs in plasmid DNA.Methods Luciferase-expressing plasmids with differing CpG content were injected into the tail vein of mice by the hydrodynamic injection method. The effects of CpG content on the duration of transgene expression were examined, focusing on cytosine methylation and pro-inflammatory cytokines. Based on the findings, IFN-gamma-expressing plasmids were constructed and their transgene expression and inhibitory effect oil pulmonary metastasis were evaluated.Results Plasmids with a few CpG motifs showed a prolonged luciferase activity in the liver. Methylation of CpG motifs in plasmids reduced the expression and the extent of this reduction was greater for plasmids with a high CpG content. Pro-inflammatory cytokines hardly affected the expression. pCpG-Mu gamma, the IFN-gamma-expressing plasmid, which contains 20 CpG motifs only in the cDNA region, exhibited a sustained IFN-gamma concentration at therapeutic levels, and had a great inhibitory effect on the pulmonary metastasis of Minor cells.Conclusions The duration of transgene expression of IFN-gamma was successfully increased by reducing the CpG content of IFN-expressing plasmid vector, which resulted in art increased anticancer activity of IFN gene transfer. Copyright (C) 2009 John Wiley & Sons, Ltd.